Prostate Cancer: Evidence-Based Approach to Screening and Treatment

Publish Date: March 1, 2011 Last Modified: December 21, 2017 Expires: February 14, 2013
This course has been expired.

UPMC urologist, Dr. Joel B. Nelson, presents the pros and cons of prostate cancer screening. This presentation was part of UPMC’s Update in Internal Medicine 2010: Evidence-Based Approaches to Common Medical Problems.

Learning Objectives:

  • Articulate the pros and cons of screening for prostate cancer
  • Describe the importance of active surveillance in disease management
  • Develop a more informed screening and treatment protocol

Disclosure: Dr. Nelson is a consultant for Astra-Zeneca, AmGen, Millenium/Tekeda, Roche Diagnostics, Bayer Healthcare, Centocor, Orthro Biotech, Atlab Pharma, and CARIS.

Accreditation Statement

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this educational activity for a maximum of .5 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of their participation in the activity.

Release Date 2/14/2011 | Review Date 2/14/2012 | Expiration Date 2/13/2013

This course has been expired.

Presenters

  • Joel B Nelson MD
    Joel B. Nelson, MD
    Dr. Joel Nelson is the Frederic N. Schwentker Professor and chairman of the Department of Urology, University of Pittsburgh School of Medicine. He also serves as the co-director of the Prostate and Urologic Cancer Center at the University of Pittsburgh Cancer Institute. Dr. Nelson earned his medical degree from Northwestern University. Following surgical and urological residencies at the McGraw Medical Center of Northwestern University and a fellowship at the Brady Urological Institute, he was assistant professor of urology and oncology at the Johns Hopkins University School of Medicine, and director of Urologic Oncology at the Johns Hopkins Bayview Medical Center. Dr. Nelson's clinical interests include prostate cancer and other urinary tract malignancies. He is one of the country's leading surgeons performing nerve-sparing radical prostatectomy, an operation in which a cancerous prostate gland is removed but the nerves controlling erections are not. His research focuses on new ways to treat advanced prostate cancer that no longer responds to hormone therapy. Dr. Nelson is on the board of consulting editors for the scientific journal Urology and is an ad hoc reviewer for numerous other medical publications, including The New England Journal of Medicine. He is board certified by the American Board of Urology.
    full profile

Related Courses